These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26836031)

  • 21. Genetic drift influenza A(H3N2) virus hemagglutinin (HA) variants originated during the last pandemic turn out to be predominant in the 2011-2012 season in Northern Italy.
    Pariani E; Amendola A; Ebranati E; Ranghiero A; Lai A; Anselmi G; Zehender G; Zanetti A
    Infect Genet Evol; 2013 Jan; 13():252-60. PubMed ID: 23174527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ιnfluenza A(H3N2) genetic variants in vaccinated patients in northern Greece.
    Melidou A; Gioula G; Exindari M; Ioannou E; Gkolfinopoulou K; Georgakopoulou T; Tsiodras S; Papa A
    J Clin Virol; 2017 Sep; 94():29-32. PubMed ID: 28734139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic changes in influenza A(H3N2) viruses circulating during 2011 to 2013 in northern India (Lucknow).
    Jain A; Dangi T; Jain B; Singh AK; Singh JV; Kumar R
    J Med Virol; 2015 Aug; 87(8):1268-75. PubMed ID: 25914198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic diversity of influenza A(H3N2) viruses in Northern Cameroon during the 2014-2016 influenza seasons.
    Njifon HLM; Monamele CG; Vernet MA; Njankouo MR; Deweerdt L; Nono R; Kenmoe S; Mbacham W; Njouom R
    J Med Virol; 2019 Aug; 91(8):1400-1407. PubMed ID: 30866072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hemagglutinin gene of influenza A (H3N2) virus from human samples in the 2009 influenza epidemic in Chengdu].
    Long DL; Zhang XC; Cao RR; Deng Q; Liu HC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):260-3. PubMed ID: 21500568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interim estimates of divergence date and vaccine strain match of human influenza A(H3N2) virus from systematic influenza surveillance (2010-2015) in Hangzhou, southeast of China.
    Li J; Zhou YY; Kou Y; Yu XF; Zheng ZB; Yang XH; Wang HQ
    Int J Infect Dis; 2015 Nov; 40():17-24. PubMed ID: 26417878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).
    Skowronski DM; Sabaiduc S; Leir S; Rose C; Zou M; Murti M; Dickinson JA; Olsha R; Gubbay JB; Croxen MA; Charest H; Bastien N; Li Y; Jassem A; Krajden M; De Serres G
    Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the lookout for influenza viruses in Italy during the 2021-2022 season: Along came A(H3N2) viruses with a new phylogenetic makeup of their hemagglutinin.
    Galli C; Pellegrinelli L; Giardina F; Ferrari G; Uceda Renteria SC; Novazzi F; Masi E; Pagani E; Piccirilli G; Mauro MV; Binda S; Corvaro B; Tiberio C; Lalle E; Maggi F; Russo C; Ranno S; Vian E; Pariani E; Baldanti F; Piralla A;
    Virus Res; 2023 Jan; 324():199033. PubMed ID: 36581046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
    Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M
    Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surveillance for influenza A virus infections in infants and young children in Beijing, China, 2001-2005].
    Zhu RN; Qian Y; Wang F; Deng J; Zhao LQ; Liao B; Che L
    Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):518-22. PubMed ID: 17044978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons.
    Monamele GC; Vernet MA; Njankouo MR; Victoir K; Akoachere JF; Anong D; Njouom R
    PLoS One; 2017; 12(9):e0184411. PubMed ID: 28877235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of antigenic and genetic changes in the hemagglutinins of influenza A/H3N2 viruses of three consecutive seasons (2002/2003 to 2004/2005) in Austria.
    Redlberger M; Aberle SW; Heinz FX; Popow-Kraupp T
    Vaccine; 2007 Aug; 25(32):6061-9. PubMed ID: 17601639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic and antigenic divergence in the influenza A(H3N2) virus circulating between 2016 and 2017 in Thailand.
    Suntronwong N; Klinfueng S; Vichiwattana P; Korkong S; Thongmee T; Vongpunsawad S; Poovorawan Y
    PLoS One; 2017; 12(12):e0189511. PubMed ID: 29252990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic characterization of influenza A(H3N2) viruses circulating in coastal Kenya, 2009-2017.
    Owuor DC; Ngoi JM; Otieno JR; Otieno GP; Nyasimi FM; Nyiro JU; Agoti CN; Chaves SS; Nokes DJ
    Influenza Other Respir Viruses; 2020 May; 14(3):320-330. PubMed ID: 31943817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.
    Skowronski DM; Chambers C; Sabaiduc S; Dickinson JA; Winter AL; De Serres G; Drews SJ; Jassem A; Gubbay JB; Charest H; Balshaw R; Bastien N; Li Y; Krajden M
    Euro Surveill; 2017 Feb; 22(6):. PubMed ID: 28205503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-infection with influenza A/H1N1 and A/H3N2 viruses in a patient with influenza-like illness during the winter/spring of 2008 in Shanghai, China.
    Ju L; Jiang L; Yang J; Shi Q; Jiang Q; Shen H; Tan Y; Lu Y
    J Med Virol; 2010 Aug; 82(8):1299-305. PubMed ID: 21280055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Pyrosequencing-Based Approach to High-Throughput Identification of Influenza A(H3N2) Virus Clades Harboring Antigenic Drift Variants.
    Mishin VP; Baranovich T; Garten R; Chesnokov A; Abd Elal AI; Adamczyk M; LaPlante J; St George K; Fry AM; Barnes J; Chester SC; Xu X; Katz JM; Wentworth DE; Gubareva LV
    J Clin Microbiol; 2017 Jan; 55(1):145-154. PubMed ID: 27795346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving influenza virological surveillance in Europe: strain-based reporting of antigenic and genetic characterisation data, 11 European countries, influenza season 2013/14.
    Broberg E; Hungnes O; Schweiger B; Prosenc K; Daniels R; Guiomar R; Ikonen N; Kossyvakis A; Pozo F; Puzelli S; Thomas I; Waters A; Wiman Å; Meijer A
    Euro Surveill; 2016 Oct; 21(41):. PubMed ID: 27762211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct molecular evolution of influenza H3N2 strains in the 2016/17 season and its implications for vaccine effectiveness.
    Kim JI; Park S; Chu H; Lee I; Bae JY; Yoo K; Kim J; Lee JY; Lee N; Kim M; Kim JS; Hong KW; Jun KR; Lee JN; Kim K; Park MS
    Mol Phylogenet Evol; 2019 Feb; 131():29-34. PubMed ID: 30399431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza A(H3N2) virus variants and patient characteristics during a summer influenza epidemic in Taiwan, 2017.
    Tsou TP; Su CP; Huang WT; Yang JR; Liu MT
    Euro Surveill; 2017 Dec; 22(50):. PubMed ID: 29258649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.